Renagel and Prandin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Renagel (sevelamer hydrochloride) and Prandin (repaglinide). Common drug interactions include asthenia among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Renagel and Prandin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Renagel?

Renagel has active ingredients of sevelamer hydrochloride. eHealthMe is studying from 8,246 Renagel users. Check the latest studies of Renagel.

What is Prandin?

Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,680 Prandin users. Check the latest studies of Prandin.



On Jul, 25, 2026

22 people who take Renagel and Prandin together, and have interactions are studied.

Renagel and Prandin drug interactions.

What are the common drug interactions of Renagel and Prandin, by gender? *:

female:

  1. Asthenia (weakness)
  2. Dry skin
  3. Fatigue (feeling of tiredness)
  4. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  5. Joint stiffness
  6. Joint swelling
  7. Muscle tightness
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Myalgia (muscle pain)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

male:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Muscle tightness
  4. Oedema (fluid collection in tissue)
  5. Oedema peripheral (superficial swelling)
  6. Pain
  7. Pneumonia
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Renal failure chronic (long lasting kidney dysfunction)

What are the common drug interactions of Renagel and Prandin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Asthenia (weakness)
  5. Dry skin
  6. Erythema (redness of the skin)
  7. Gait disturbance
  8. Injury
  9. Joint range of motion decreased (disease of joint movement)
  10. Muscle tightness

60+:

  1. Asthenia (weakness)
  2. Dry skin
  3. Nodule on extremity (a small rock or mineral cluster on hands or legs)
  4. Oedema (fluid collection in tissue)
  5. Pain in extremity
  6. Pruritus (severe itching of the skin)
  7. Rash papular (redness with papule)
  8. Skin hyperpigmentation (disorders affect the colour of your skin)
  9. Skin hypertrophy (skin cells enlarges)
  10. Skin tightness

What are the existing conditions these people have? *

  1. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 9.09%
  2. Conjunctivitis (pink eye): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Renagel and Prandin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Renagel and Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Renagel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Renagel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prandin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sevelamer hydrochloride and repaglinide (the active ingredients of Renagel and Prandin, respectively), and Renagel and Prandin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: